However, we now know that immunophenotypic categorization is insufficient to entirely explain variability in prognosis and therapeutic response, with recurrent chromosomal alterations and mutations playing a highly significant role.
1
—
—
However, we now know that immunophenotypic categorization is insufficient to entirely explain variability in prognosis and therapeutic response, with recurrent chromosomal alterations and mutations playing a highly significant role.